Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis

Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis

Translocation and transcription factor E3 (TFE3)-rearranged renal cell carcinoma (RCC) is a rare subtype of RCCs characterised by the fusion of the TFE3 transcription factor genes on chromosome Xp11.2 with one of the multiple genes. TFE3-rearranged RCC occurs mainly in children and adolescents, alt...

Full description

Bibliographic Details
Main Authors:	Sho Murakami, Keita Nagawa, Takanori Inui, Aya Yamamoto, Mizuka Suzuki, Fumitaka Koga, Toru Motoi, Yasunobu Takaki
Format:	Article
Language:	English
Published:	Codon Publications 2023-09-01
Series:	Journal of Kidney Cancer and VHL
Subjects:	case reports FDG PET-CT SUVmax TFE3-rearranged Xp11.2 translocation
Online Access:	https://mail.jkcvhl.com/index.php/jkcvhl/article/view/266

Similar Items

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
by: Yan Ge, et al.
Published: (2021-11-01)

TFE3-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour
by: Alessandro Pietro Aldera, et al.
Published: (2022-05-01)

The incidence of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in Saudi adult patients with renal cancer: a retrospective tissue microarray analysis
by: Jaudah Al-Maghrabi, et al.
Published: (2019-01-01)

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
by: Jiale Zhou, et al.
Published: (2022-07-01)

Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma
by: Xiang Dong, et al.
Published: (2022-10-01)

TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma
by: Junyi Lin, et al.
Published: (2023-05-01)

Xp11 Translocation Renal Cell Carcinoma: Unusual Variant Masquerading as Upper Tract Urothelial Cell Carcinoma
by: Arash Akhavein, et al.
Published: (2014-05-01)

Gender difference analysis of Xp11.2 translocation renal cell carcinomas’s attack rate: a meta-analysis and systematic review
by: Wenyuan Zhuang, et al.
Published: (2020-08-01)

Primary Xp11 translocation PEComa of the testis with SFPQ⁃TFE3 rearrangement: a case report and review of the literature
by: Huizhi Zhang, et al.
Published: (2023-01-01)

Bilateral Xp11.2 translocation renal cell carcinoma: a case report
by: Takashi Karashima, et al.
Published: (2018-11-01)

A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3‐rearranged renal cell carcinoma
by: Pengju Li, et al.
Published: (2024-03-01)

Estradiol increases risk of topoisomerase IIβ-mediated DNA strand breaks to initiate Xp11.2 translocation renal cell carcinoma
by: Qiancheng Shi, et al.
Published: (2021-11-01)

Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis
by: Zhu Y, et al.
Published: (2021-03-01)

The preliminary experiences of translocation renal cell carcinoma and literature review
by: Hsin-Hao Su, et al.
Published: (2014-08-01)

Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
by: Wei Guo, et al.
Published: (2023-02-01)

Are tumor-associated micro-angiogenesis and lymphangiogenesis considered as the novel prognostic factors for patients with Xp11.2 translocation renal cell carcinoma?
by: Wenliang Ma, et al.
Published: (2020-12-01)

Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report
by: Wenpeng Huang, et al.
Published: (2023-09-01)

MiT/TFE Family Renal Cell Carcinoma
by: Jinglong Tang, et al.
Published: (2023-01-01)

Emerging roles and regulation of MiT/TFE transcriptional factors
by: Min Yang, et al.
Published: (2018-06-01)

SEARCH FOR ARE REGULATORY SEQUENCES IN GENES of MASTER REGULATORS OF autophagy and LYSOSOMAL BIOGENESIS TFEB AND TFE3
by: A. V. Chechushkov, et al.
Published: (2019-02-01)

Sarcomatoid variant of Xp11 translocation renal cell carcinoma: A rare case report in an adult female
by: Rakhi V Jagdale, et al.
Published: (2024-01-01)

Melanotic Xp11 translocation renal cancer: a report of a distinctive case and a review of the literature
by: Hongbiao Jing, et al.
Published: (2018-08-01)

The Value of Semiquantitative Parameters Derived from <sup>18</sup>F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer
by: Luca Urso, et al.
Published: (2022-11-01)

MiT family translocation renal cell carcinoma with retroperitoneal metastasis in childhood: a case report
by: Kaihang Yang, et al.
Published: (2023-07-01)

TFE3-rearranged renal cell carcinoma with tumour thrombus in the ureter mimicking invasive transitional cell carcinoma
by: Arman Z. Chacko, et al.
Published: (2023-11-01)

Beyond lymph nodes: 18F-FDG PET/CT in detection of unusual sites of extranodal lymphoma
by: Amal Ibrahim Ahmed Othman, et al.
Published: (2019-09-01)

Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
by: Tarik Sengoz, et al.
Published: (2023-04-01)

Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers
by: Jee Soo Park, et al.
Published: (2022-01-01)

Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma
by: Carolin Prexler, et al.
Published: (2022-12-01)

Multiple myeloma: characterization of patients through the analysis of semiquantitative parameters with 18F-FDG PET
by: Maria Silvia De Feo, et al.
Published: (2023-06-01)

Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials
by: Anne-Victoire Michaud-Robert, et al.
Published: (2020-09-01)

TFEB and TFE3 drive kidney cystogenesis and tumorigenesis
by: Chiara Di Malta, et al.
Published: (2023-05-01)

A Preliminary Study to Use SUVmax of FDG PET-CT as an Identifier of Lesion for Artificial Intelligence
by: Kenji Hirata, et al.
Published: (2021-04-01)

TFE3-Expressing Perivascular Epithelioid Cell Tumor of the Breast
by: Hyunjin Kim, et al.
Published: (2019-01-01)

Kidney carcinoma associated with Xp11.2 translocation / TFE3 (ASPL-TFE3) gene fusion
by: Paulo G. O. Salles, et al.
Published: (2005-06-01)

Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entities
by: Yang Liu, et al.
Published: (2023-04-01)

Significance of metabolic parameters and biochemical indexes of 18F-FDG PET/CT in the mid-term evaluation and prognosis of diffuse large B-cell lymphoma
by: Zhang Fan, Zhang Guoxu, Liu Xiuting, Wang Jigang, Liu Yanqin, Tong Danjiang, Liu Jinghua, Zhou Fan
Published: (2022-03-01)

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma
by: Aino Rajamäki, et al.
Published: (2023-01-01)

18F-FDG positron emission tomography in the diagnosis and staging of marginal zone non-Hodgkin lymphomas
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma:a case report
by: Haiyang Yang, et al.
Published: (2023-10-01)